UGT1A1 and metabolic dysfunction-associated steatotic liver disease: As shown in the Table 2, no significant correlation was found between the circulating level of UGT1A1 with liver fat fraction in NAFLD patients (ρ = 0.080, P = 0.179) and all subjects (ρ = 0.088, P = 0.256).